Remedium unveils Rights Issue post Rs. 182.7 crore UK deal to drive global expansion
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Rising demands and advancements in eye care drive growth
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
The company does not expect this development to have any material impact on the current business operations
Subscribe To Our Newsletter & Stay Updated